Alfacalcidol increases cancellous bone in low turnover, fatty marrow sites in aged, orchidectomized rats

Journal of Musculoskeletal Neuronal Interactions

Volumn 9, Issue 3, 2009, Pages 138-146

  Tian, X Y ^a   Chen, H Y ^a   Setterberg, R B ^a   Li, M ^b   Jee, Webster S S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

Author keywords

Alfacalcidol; Bone balance; Bone turnover; Histomorphometry; Orchidectomy

Indexed keywords

ALFACALCIDOL;

AGING; ANDROGEN DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MASS; BONE STRUCTURE; BONE TURNOVER; CANCELLOUS BONE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; LUMBAR VERTEBRA; MALE; METAPHYSIS; NONHUMAN; ORCHIECTOMY; OSTEOLYSIS; RAT; TIBIA; TISSUE DISTRIBUTION; TREATMENT DURATION; VERTEBRA BODY;

ADIPOSE TISSUE; AGING; ANDROGENS; ANIMALS; BONE AND BONES; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE DEVELOPMENT; BONE MARROW; HYDROXYCHOLECALCIFEROLS; MALE; ORCHIECTOMY; OSTEOPOROSIS; RATS; RATS, SPRAGUE-DAWLEY; TIBIA; TREATMENT OUTCOME;

EID: 73249144127     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Ma YF, Ke HZ, Jee WSS. Prostaglandin E2 adds bone to a cancellous bone site with a closed growth plate and low bone turnover in ovariectomized rats. Bone 1994;15:137-46.
2. Ijiri K, Ma YF, Jee WSS, Akamine T, Liang X. Adaptation of non-growing former epiphysis and metaphyseal trabecular bones to aging and immobilization in rat. Bone 1995;17(Suppl.4):S207-12.
3. Li M, Shen Y, Qi H, Wronski TJ. Comparative study of skeletal response to estrogen depletion at red and yellow marrow sites in rats. Anat Rec 1996;245:472-80.
4. Wronski TJ, Dann LM, Horner SL. Time course of vertebral osteopenia in ovariectomized rats. Bone 1989;10:295-301.
5. Wronski TJ, Dann LM, Scott KS, Cintrfin M. Longterm effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int 1989;45:360-6.
6. Li M, Liang H, Shen Y, Wronski TJ. Parathyroid hormone stimulates cancellous bone formation at skeletal sites regardless of marrow composition in ovariectomized rats. Bone 1999;24:95-100.
7. Shiraishi A, Takeda A, Masaki T, Higuchi Y, Uchiyama Y, Kubodera N, Sato K, Ikeda K, Nakamura T, Matsumoto T, Ogata E. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen. J Bone Miner Res 2000;15:770-9.
8. Shiraishi A, Higashi S, Masaki T, Saito M, Ito M, Ikeda S, Nakamura T. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss in an ovariectomized rat model of osteoporosis. Calcif Tissue Int 2002;71:69-79.
9. Nishikawa T, Ogawa S, Kogita K, Manabe N, Katsumata T, Nakamura K, Kawaguchi H. Additive effects of combined treatment with etidronate and alfa-calcidol on bone mass and mechanical properties in ovariectomized rats. Bone 2000;27:647-54.
10. Li M, Healy DR, Simmons HA, Ke HZ, Thompson DD. Alfacalcidol restores cancellous bone in ovariectomized rats. J Musculoskelet Neuronal Interact 2003;3:39-46.
11. Li M, Healy DR, Li Y, Simmons HA, Su M, Jee WSS, Shen VW, Thompson DD. Alfacalcidol prevents age-related bone loss and causes an atypical pattern of bone formation in aged male rats. J Musculoskelet Neuronal Interact 2004;4:22-32.
12. Chen HY, Tian XY, Liu XQ, Setterberg RB, Li M, Jee WSS. Alfacalcidol stimulated focal bone formation on the cancellous surface and increased bone formation on the periosteal bone surface of the lumbar vertebra of adult female rats. Calcif Tissue Int 2008;82:127-36.
13. Liu XQ, Chen HY, Tian XY, Setterberg RB, Li M, Jee WSS. Alfacalcidol treatment increases bone mass and strength from anti-catabolic and anabolic effects on cancellous and cortical bone in intact female rats. J Bone Miner Metab 2008;26:425 35.
14. Tian XY, Liu XQ, Chen HY, Setterberg RB, Li M, Jee WSS. Greater efficacy of alfacalcidol in the red than in the yellow marrow skeletal sites in adult female rats. J Musculoskeletal Neuronal Interact 2008;8:257-66.
15. Jee WSS, Inoue J, Jee KW, Haba T. Histomorphometric assay of the growing long bone. In: Takahashi H, editor. Handbook of Bone Morphology. Niigata Japan: Nishimura; 1983. p. 101-103.
16. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS. Relationships between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 1983;72:1296-409.
17. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PF, Ott SM, Recker RR. Bone histomorphometry: Standardization of nomenclature, symbols and units. J Bone Miner Res 1987;2:595-610.
18. Compston JE, Mellish RWE, Garrahan NJ. Age-related changes in iliac crest trabecular microanatomic bone structure in man. Bone 1987;8:289-92.
19. Compston JE, Mellish RWE, Croucher P, Newcombe R, Garrahan JH. Structural mechanisms of trabecular bone loss in man. Bone Miner 1989;6:339-50.
20. 2 and risedronate is better than PGE2 alone in the long-term treatment of ovariectomized-induced osteopenic rats. Bone 1995;17(Suppl.4):S267-72.
21. Erben RG. Vitamin D analogs and bone. J Musculoskelet Neuronal Interact 2001;2:59-69.
22. Erben RG, Eberle J, Stahr K, Goldberg M. Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study. J Bone Miner Res 2000;15:1085-98.
23. Erben RG, Weiser H, Sinowatz F, Rambeck WA, Zucker H. Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats. Calcif Tissue Int 1992;50:228-36.
24. 3 and calcium in osteopenic ovariectomized rats: evidence for a direct anabolic effect of 1α,25-dihydroxyvitamin D3 on bone. Endocrinology 1998;139:4319-28.
25. 3 on ovariectomy-induced cancellous bone loss in the rat. Calcif Tissue Int 1997;60:434-40.
26. 3. J Bone Miner Res 2002;17:1498-511.
27. Tanaka Y, Nakamura T, Nishida S, Suzuki K, Takeda S, Sato K, Nishii Y. Effects of a synthetic vitamin D ana log, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats. J Bone Miner Res 1996;11:325-36.
28. Riggs BL, Parffit AM. Perspective. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res 2005;20:177-84.
29. Brandi ML, Collin-Osdoby P. Vascular biology and the skeleton. J Bone Miner Res 2006;21:183-92.
30. Eriksen EF, Eghbali-Fatourechi GZ, Khosla S. Remodeling and vascular spaces in bone. J Bone Miner Res 2007;22:1-6.
31. Hauge EM, Qvesel D, Eriksen EF, Mosekilde L, Melsen F. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 2001;16:1575-82.
32. Kuznetsov SA, Mankani MH, Gronthos S, Satomura K, Bianco P, Robey PG. Circulating skeletal stem cells. J Cell Biol 2001;153:1133-40.
33. Eghbali-Fatourechi GZ, Lamsam J, Fraser D, Nagel D, Riggs BL, Khosia S. Circulating osteoblast-lineage cells in humans. N Engl J Med 2005;352:1959-66.
34. Centrella M, McCarthy TL, Canalis E. Transforming growth factor-beta and remodeling of bone. J Bone Joint Surg Am 1991;73:1418-28.
35. Baylink DJ, Finkelman RD, Mohan S. Growth factors to stimulate bone formation. J Bone Miner Res 1993;8(Suppl.2):S565-72.
36. Mundy GR, Bonewald LF. Role of TGF beta in bone remodeling. Ann NY Acad Sci 1990;593:91-7.
37. Karsdal MA, Martin TJ, Bollerslev J, Christiansen C, Henriksen K. Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res 2007;22:487-94.
38. Miller SC, Bowman BM, Smith JM, Jee WSS. Characterization of endosteal bone-lining cells from fatty bone sites in adult beagles. Anat Rec 1980; 198:163-73.
39. Miller SC, Jee WSS. The bone forming cells: Origin, distribution proliferation and differentiation. In: Takahashi HE, editor. Bone Morphometry. Niigata: Nishimura and London: Smith-Gordon; 1988. 29, 36.
40. Erben RG, Kohn B, Weiser H, Sinowatz F, Rambeck WA. Role of vitamin D metabolites in the prevention of the osteopenia induced by ovariectomy in the axial and appendicular skeleton of the rat. A Ernährungswiss 1990;29:229-48.
41. Jee WSS, Tian XY, Setterberg RB. Cancellous bone minimodeling-based formation: a Frost, Takahashi legacy. J Musculoskelet Neuronal Interact 2007;7:232-9.
42. Erben RG. Trabecular and endocortical bone surfaces in the rat: modeling or remodeling? Anat Rec 1996;246:39-46.
43. Kobayashi S, Takahashi HE, Ito A, Saito N, Nawata M, Horiuchi H, Ohta H, Ito A, Iorio R, Yamamoto N, Takaoka K. Trabecular minimodeling in human iliac bone. Bone 2003;32:163-9.
44. O'Donnell S, Moher D, Thomas K, Hanley DA, Cranney A. Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls. J Bone Miner Metab 2008;26:531-42.
45. Brown EM. Calcium-sensing receptor. In: Favus MJ, editor. Primer on Metabolic Diseases and Disorders on Mineral Metabolism, Fifth Edition. Washington DC, ASBMR; 2003. p. 111-117.
46. McKane WR, Khosla S, Egan KS, Robins SP, Burritt MF, Riggs BL. Role of calcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab 1996;81:1699-703.
47. Blair HC, Simonet S, Lacey DL, Zidi M. Osteoclast biology. In: Marcus R, Feldman D, Nelson D, Rosen CJ, editors. Osteoporosis, Third Edition, Volume I. Amsterdam, Elsevier Academic Press; 2008. p. 151-168.